Vehicle Automation Impact on Drivers

NCT ID: NCT03893006

Last Updated: 2021-07-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-08

Study Completion Date

2023-07-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the context of ever-increasing automation in surface vehicles, automation impact on drivers will be investigated through three complementary research axes undertaken under simulated driving:

Axe 1 (Cognitive ergonomics), how automation is impacting driving behaviors and visual explorations? Axe 2 (Experimental psychology), how automation is impacting drivers' mental representations of their own driving abilities? Axe 3 (Neuroimaging), how automation is modifying the car driving neural network? And what are drivers' mental representations neural bases? The project tackle both applied and basic research issues using an original experimental neuro ergonomics approach. AUTODRIVE will bring original data on human-machine cooperation, mental representations, cognitive control and brain processes depending on the characteristics of the automation used over a significant period of time (six weeks) on a large sample (N=120) of experienced and inexperienced drivers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Behaviors Driving Automation Neuroimaging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

UnAssisted (UA)

This term refers to driving a vehicle manually without any vehicle automation technology. It will serve as a baseline concerning behaviors, representations and neural results associated with unassisted automobile driving.

Group Type EXPERIMENTAL

Level of vehicle automation

Intervention Type DEVICE

From no automation of the vehicle to full automation through warnings, shared control and partly automated automation levels.

Assisted (A)

This term refers to driving with warning technology which upon activation sounds an a warning when the vehicle is too close to the edge of the road (off-road warning , Navarro, Mars, \& Hoc, 2007; Suzuki \& Jansson, 2003) or too close to the vehicle in front of it (anti-collision warning; Lee, McGehee, Brown, \& Reyes, 2002).

Group Type EXPERIMENTAL

Level of vehicle automation

Intervention Type DEVICE

From no automation of the vehicle to full automation through warnings, shared control and partly automated automation levels.

Shared Control (SC)

This term refers to shared tactical control between the driver and the automated assistive technology, both working simultaneously on the physical trajectory of the vehicle, laterally (Griffiths \& Gillespie, 2005; Mulder, Abbink, \& Boer, 2012) as well as longitudinal (Adell, Várhelyi, \& Hjälmdahl, 2008).

Group Type EXPERIMENTAL

Level of vehicle automation

Intervention Type DEVICE

From no automation of the vehicle to full automation through warnings, shared control and partly automated automation levels.

Partly Autonomous (PA)

This term refers to a situation where the lateral and longitudinal control of the driving are delegated to the automated assistive technology. It consists of a level of automatisation that today is possible to put into application and which often is referred to by the name "Highly Automated Driving" (Navarro, 2018). In this case, the driver is no longer the one who physically ensures the lateral and longitudinal control of the vehicle, but instead supervises the actions of the automated assistive technology.

Group Type EXPERIMENTAL

Level of vehicle automation

Intervention Type DEVICE

From no automation of the vehicle to full automation through warnings, shared control and partly automated automation levels.

Fully Autonomous (FA)

This term refers to a completely automated driving experience. The on-board technologies take over all the driving tasks for any driving situation.

Group Type EXPERIMENTAL

Level of vehicle automation

Intervention Type DEVICE

From no automation of the vehicle to full automation through warnings, shared control and partly automated automation levels.

Any Automation (AA)

This term refers to a situation where the drivers can choose the automation device of their choice among the five types presented above and can change it whenever they think it is good to do so.

Group Type EXPERIMENTAL

Level of vehicle automation

Intervention Type DEVICE

From no automation of the vehicle to full automation through warnings, shared control and partly automated automation levels.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Level of vehicle automation

From no automation of the vehicle to full automation through warnings, shared control and partly automated automation levels.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* To be between the ages of 22 and 45 years old
* Having given an informed consent for the study
* Being registered with the French Social Security System
* No driving license for 60 participants
* Driving license for 4 years or more for 60 participants

Exclusion Criteria

* No signature on the consent form
* Inability to read or write French.
* Neurologic or psychiatric illness, known or revealed during the inclusion visit
* Substance intake ( taking psychoactive medications or recreational drugs) on the day of the experiment
* Noise intolerance
* Need of vision glasses to drive
* Persons under curators or deprived of civil rights or deprived of their freedom
* Unable to fill a questionnaire (severe cognitive troubles)
* Subjects must not have metallic or electronic implants in the body : pacemakers or pacemaker wires, open heart surgery, artificial heart valve, brain aneurysm surgery, middle ear implant, hearing aid, braces or extensive dental work, cataract surgery or lens implant, implanted mechanical or electrical device, or artificial limb or joint o foreign metallic objects in the body (bullets, BBs, pellets, shrapnel, or metalwork fragments) or current or past employment as machinists, welders or metal workers, tattoos near the head or neck regions, permanent makeup
* Claustrophobia
Minimum Eligible Age

22 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jordan Navarro, MD

Role: PRINCIPAL_INVESTIGATOR

: Laboratoire d'Etude des Mécanismes Cognitifs (EMC) -Université Lumière Lyon 2

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Laboratoire d'Etude des Mécanismes Cognitifs (EMC)

Bron, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jordan Navarro, MD

Role: CONTACT

00 33 4 78 77 30 52

Emanuelle Reynaud, MD

Role: CONTACT

00 33 4 78 77 24 31

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jordan NAVARRO, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

69HCL19_0141

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Autobiographical Memory
NCT04584138 COMPLETED